The Johannesburg Stock Exchange has overhauled its listing requirements to accommodate high-growth companies, but questions remain about whether the changes go far enough.
The Japanese development agency is stepping beyond traditional grants, joining VCs and corporate giants to finance the expansion of a Ghanaian "phygital" healthcare provider.
Simon Hazell returns to the CEO seat at Bioshroom, betting on high-margin wellness over commodity protein after energy crises and strategic missteps shuttered his previous agritech venture.
iProcure, once a darling of the agritech scene with over $17m in total funding — including a $10.2m Series B in 2022 — collapsed into administration in May 2024.
The acquisition marks a significant liquidity event for the East African ecosystem, offering a strategic entry point for bolttech's expansion into the continent.
A flurry of regulatory approvals for British heavyweights this week coincides with a major diplomatic push from Downing Street, signaling a new era for cross-border fintech in South Africa.
The Johannesburg Stock Exchange has overhauled its listing requirements to accommodate high-growth companies, but questions remain about whether the changes go far enough.
In late 2024 and throughout 2025, the National Pensions Regulatory Authority (NPRA) tightened its grip on offshore investments, effectively blocking fund managers from moving capital abroad.
